SYENS SYENSQO

Syensqo to explore a potential US listing

Syensqo to explore a potential US listing

Syensqo to explore a potential US listing 

Brussels, Belgium – February 27, 2025 - 07h01 CET

SYENSQO SA (the “Company”) today announced that its Board of Directors approved the exploration of a potential dual listing of its shares in the United States of America, in addition to its existing Euronext Brussels listing. 

During this exploratory phase, the Board of Directors will assess the feasibility and potential benefits of an additional listing, including the ability to increase Syensqo's visibility and expand its accessibility to North American investors.

Syensqo will communicate its decision when the evaluation is completed.

Dr. Ilham Kadri, CEO: “As we complete our first full year of operations as a standalone company following our separation from Solvay, we are accelerating our transformation to become an even purer play specialty growth company. The Americas is Syensqo’s largest region, representing more than 40% of our sales and people, as well as being home to more than half our industrial footprint. In addition, as we expect a major part of our future growth and investments to be in this strategically important region, it makes sense for us to explore a U.S. listing, which has the potential added benefits of expanding and enhancing our investor base.



 

Contacts

Investors & Analysts

Media

Sherief Bakr

Bisser Alexandrov

Loïc Flament
9



0
Perrine Marchal

Laetitia Schreiber
2

7

Safe harbor

This press release may contain forward-looking information. Forward-looking statements describe expectations, plans, strategies, goals, future events or intentions. The achievement of forward-looking statements contained in this press release is subject to risks and uncertainties relating to a number of factors, including general economic factors, interest rate and foreign currency exchange rate fluctuations, changing market conditions, product competition, the nature of product development, impact of acquisitions and divestitures, restructurings, products withdrawals, regulatory approval processes, all-in scenario of R&I projects and other unusual items. Consequently, actual results or future events may differ materially from those expressed or implied by such forward-looking statements. Should known or unknown risks or uncertainties materialize, or should our assumptions prove inaccurate, actual results could vary materially from those anticipated. The Company undertakes no obligation to publicly update or revise any forward-looking statements.

About Syensqo 

Syensqo is a science company developing groundbreaking solutions that enhance the way we live, work, travel and play. Inspired by the scientific councils which Ernest Solvay initiated in 1911, we bring great minds together to push the limits of science and innovation for the benefit of our customers, with a diverse, global team of more than 13,000 associates.

Our solutions contribute to safer, cleaner, and more sustainable products found in homes, food and consumer goods, planes, cars, batteries, smart devices and health care applications. Our innovation power enables us to deliver on the ambition of a circular economy and explore breakthrough technologies that advance humanity.

Investor Relations sources

















Attachment



EN
27/02/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on SYENSQO

 PRESS RELEASE

Syensqo completes the second tranche of its €300 million Share Buyback...

Syensqo completes the second tranche of its €300 million Share Buyback Program Syensqo completes the second tranche of its €300 million Share Buyback Program Brussels, Belgium – February 28, 2024 17:45 CET Syensqo SA is pleased to announce the successful completion of the second tranche of its share buyback program (the “program”), on December 4, 2024 and concluded on February 26, 2025. A total of 655,783 shares were purchased, of which 185,000 have already been cancelled on 30 December 2024. Since 13 January, 2025, a total of 470,783 shares were purchased, representing approxi...

Wim Hoste
  • Wim Hoste

Syensqo Feedback conference call

Below are the highlights from the FY24 results conference call. We remind that 4Q underlying EBITDA was up 5% organically, being 1% above consensus and 2% below our forecast. FY25 underlying EBITDA of at least € 1.4bn (roughly flat vs FY24) is at the bottom c 5% below CSS and 6.6% below KBCS forecast. Syensqo will explore a dual listing in the US and aims to divest Oil&Gas and Aroma in an effort to create shareholder value. Despite the weaker than expected FY25 guidance, we still appreciate Syen...

Aaron Brodjanac ... (+7)
  • Aaron Brodjanac
  • Baptiste Salaville
  • Chaima Ferrandon
  • Charlotte Vaisse
  • Marc Lavaud
  • Sven Edelfelt
  • Thomas Zlowodzki
Aaron Brodjanac ... (+7)
  • Aaron Brodjanac
  • Baptiste Salaville
  • Chaima Ferrandon
  • Charlotte Vaisse
  • Marc Lavaud
  • Sven Edelfelt
  • Thomas Zlowodzki
ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

Aalberts: Dividend and outlook better than expected. Ackermans & van Haaren: Anticipating an all-time-high result from core segments. Ageas: FY24 in line, strong capital, outlook for upsteams. AMG: Strong 4Q24 beat and 2025F guidance upgrade. CFE: Solid results and balance sheet, outlook weak. CMB.TECH: Cautious on outlook. Corbion: Not so sweet. CTP: Good results, 2025 outlook realistic. D'Ieteren: Boyd's Five-Year Goals. Exor: Ferrari €3bn ABB and €1bn SBB. Sofina: Further ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch